$HSTM

REBROVICK LINDA sold $174K of HSTM

REBROVICK LINDA sold 6,000 shares of HEALTHSTREAM INC (HSTM) at $29.00 ($0.17M total) on 2026-07-06 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · REBROVICK LINDA
Published Jul 7, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 7:59 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$HSTM
Neutral
medium confidence
Mentioned
$HSTM
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HSTMNeutralLow
01

Why it matters

The only new information is the size, price, and timing of the director’s sale under a pre-arranged 10b5-1 plan; it does not include guidance, contracts, or regulatory developments.

02

Market read

Traders may note the insider sale for sentiment, but the 10b5-1 structure makes it a low-conviction catalyst.

03

What to watch

The filing does not state any change in business outlook, and the disclosed post-sale holdings (51,329 shares) may not materially alter insider exposure.

Relevance 3/10Novelty 3/10Timing: filed 2026-07-07, sale dated 2026-07-06

Background

This is an SEC Form 4 insider transaction disclosure for HealthStream (HSTM) by director Linda Rebrovick.

Company-level read

Ticker impact

$HSTMNeutralMedium confidence
Context

HealthStream director Linda Rebrovick sold 6,000 shares at $29.00 on 2026-07-06 under a 10b5-1 plan, worth about $174k.

Expected impact

Likely minimal price impact; any effect is short-lived unless accompanied by other disclosures.

Evidence & confidence

The filing is an open-market sale by a director, explicitly under a pre-arranged 10b5-1 plan, with no accompanying operational or guidance change disclosed.

Market effects

No clear sector read-through from a single director 10b5-1 sale.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish fundamentals.

Key entities

  • HEALTHSTREAM INC

    US-listed company whose director insider sale is disclosed on Form 4.

  • REBROVICK LINDA

    Director who sold 6,000 shares at $29.00 under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HSTMMed

WJRJJ Ventures Discloses Investment at HealthStream with 9.6% Stake

WJRJJ Ventures disclosed a 9.6% stake in HealthStream, acquired through open-market buys and a deal at $29.50 per share. The investment includes a one-year standstill and registration rights. WJRJJ plans to hold shares for investment but may buy or sell more over time. Willis Johnson, managing member of WJRJJ, is involved in the investment.

$HSTMHigh

HEALTHSTREAM ANNOUNCES SECOND QUARTER 2026 RESULTS

HEALTHSTREAM INC (HSTM) filed an SEC Form 8-K — Results of Operations and Financial Condition. HealthStream Announces Second Quarter 2026 Results Page 1 August 3, 2026 Exhibit 99.1 Contact: Scott A. Roberts Chief Financial Officer (615) 301-3182 ir@healthstream.com Media: Mollie Condra, Ph.D. Head, Investor Relations & Communications (615) 301-3237 mollie.condra@healthstre